# Zhongke Yiwei

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhongke-yiwei

- Industry: Healthcare
- Headquarters: Suzhou, China
- Total disclosed funding: $1.4M
- Latest round: Angel (Nov 9, 2023)
- Investors on record: 1

## About

Based in Suzhou, China and founded in 2022, Suzhou Zhongke Yiwei Technology Development Co., Ltd., trading as Zhongke Yiwei, is a medical device company that focuses on providing precision diagnostic products and services for exosomes. The company's core team has cross-disciplinary expertise in nanoscience, chemistry, biology and medicine, as well as extensive IVD (In Vitro Diagnostics) experience. In March 2026, Zhongke Yiwei closed Pre-series A funding from Changchun Equity Investment Fund Management.
The company's main business is exosome diagnostic product development, production, sales and service.
The company generates revenue by doing R&D, and providing exosome diagnostic products and other related services.
The Pre-series A funding raised in March 2026 will be used to support Zhongke Yiwei's research and development and industrialization process in the field of precision medicine for oncology and neurodegenerative diseases.

## Funding rounds

- Angel, Nov 9, 2023, $1.4M — CAS Venture Capital

## Investors

- CAS Venture Capital (https://capitalatlas.ai/funds/cas-venture-capital) — Angel